JP2006512077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512077A5 JP2006512077A5 JP2004564004A JP2004564004A JP2006512077A5 JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5 JP 2004564004 A JP2004564004 A JP 2004564004A JP 2004564004 A JP2004564004 A JP 2004564004A JP 2006512077 A5 JP2006512077 A5 JP 2006512077A5
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- cell
- test compound
- absence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/328,997 US20030232745A1 (en) | 2001-06-26 | 2002-12-24 | Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection |
| PCT/US2003/041093 WO2004058953A1 (en) | 2002-12-24 | 2003-12-22 | Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512077A JP2006512077A (ja) | 2006-04-13 |
| JP2006512077A5 true JP2006512077A5 (https=) | 2007-02-15 |
Family
ID=32680776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004564004A Withdrawn JP2006512077A (ja) | 2002-12-24 | 2003-12-22 | Ｃ型肝炎ウイルスの感染を阻害するための、ｄｃ−ｓｉｇｎおよびｄｃ−ｓｉｇｎｒの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030232745A1 (https=) |
| EP (1) | EP1583824A4 (https=) |
| JP (1) | JP2006512077A (https=) |
| AU (1) | AU2003299856A1 (https=) |
| CA (1) | CA2511243A1 (https=) |
| WO (1) | WO2004058953A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1046651A1 (en) * | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| US7022323B2 (en) * | 2001-06-26 | 2006-04-04 | Progenics Pharmaceuticals, Inc. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| WO2004026326A2 (en) * | 2002-09-20 | 2004-04-01 | Stichting Katholieke Universiteit | Antigen uptake receptor for candida albicans on dendritic cells |
| WO2004026909A2 (en) * | 2002-09-20 | 2004-04-01 | Stichting Katholieke Universiteit | Method of treating rheumatoid arthritis by interfering with expression of dc-sign by macrophages and diagnosis thereof |
| WO2005058244A2 (en) * | 2003-12-15 | 2005-06-30 | Alexion Pharmaceuticals, Inc. | Novel anti-dc-sign antibodies |
| PL1797112T3 (pl) * | 2004-09-29 | 2011-04-29 | The Administrators Of The Tulane Educational Fund | Inhibitory wirusa zapalenia wątroby typu C |
| EP1976596B1 (en) | 2005-12-01 | 2013-07-31 | Government Of The United States Of America, As Represented By The Secretary, Department of Health Human Services | Anti-viral griffithsin compounds, compositions, and methods of use |
| WO2013069749A1 (ja) * | 2011-11-10 | 2013-05-16 | 興和株式会社 | 生物由来の生理活性物質の測定方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US184150A (en) * | 1876-11-07 | Improvement in cultivating-harrows | ||
| US300971A (en) * | 1884-06-24 | Carriage-top | ||
| US5679342A (en) * | 1987-11-18 | 1997-10-21 | Chiron Corporation | Hepatitis C virus infected cell systems |
| SK286106B6 (sk) * | 1990-11-08 | 2008-03-05 | Novartis Vaccines & Diagnostics, Inc. | Spôsob vykonávania imunodiagnostickej skúšky na detekciu protilátky proti vírusu hepatitídy C |
| ZA927837B (en) * | 1991-10-15 | 1994-03-11 | Akzo Nv | Monoclonal antibodiesto hepatitis C virus |
| US6391567B1 (en) * | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
-
2002
- 2002-12-24 US US10/328,997 patent/US20030232745A1/en not_active Abandoned
-
2003
- 2003-12-22 AU AU2003299856A patent/AU2003299856A1/en not_active Abandoned
- 2003-12-22 JP JP2004564004A patent/JP2006512077A/ja not_active Withdrawn
- 2003-12-22 CA CA002511243A patent/CA2511243A1/en not_active Abandoned
- 2003-12-22 WO PCT/US2003/041093 patent/WO2004058953A1/en not_active Ceased
- 2003-12-22 EP EP03800130A patent/EP1583824A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sandres-Saune et al. | Determining hepatitis C genotype by analyzing the sequence of the NS5b region | |
| ES2895262T3 (es) | Cuantificación del genoma de anelovirus como biomarcador de la inmunosupresión | |
| JP2010521655A5 (https=) | ||
| Hapaurachchi et al. | Laboratory confirmation of dengue and chikungunya co-infection | |
| JP2013505007A5 (https=) | ||
| JP2006512077A5 (https=) | ||
| WO2003089929A1 (en) | Device, method, and kit for gene detection | |
| KR20200083444A (ko) | 호흡기 세포융합 바이러스 종의 니킹 및 연장 증폭 반응(near) | |
| WO1991011534A1 (en) | A rapid and sensitive test for detecting hepatitis a virus | |
| Klepper et al. | Hepatitis C virus double‐stranded RNA is the predominant form in human liver and in interferon‐treated cells | |
| CN104212914B (zh) | 埃博拉五重荧光pcr快速超敏检测试剂盒及其应用 | |
| Elkady et al. | Performance of two Real‐Time RT‐PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1–4 | |
| US20240271229A1 (en) | Reagents and Methods for Detecting HCV | |
| WO2021255151A1 (en) | Method for detecting the presence of coronavirus nucleic acid | |
| Rho et al. | Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes | |
| JP2000325099A (ja) | 新規な核酸ハイブリダイゼーション用緩衝溶液 | |
| US20080125333A1 (en) | Devices and kits for detecting one or more target agents | |
| CN102344970A (zh) | 同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒 | |
| Fabrizi et al. | Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients | |
| Ansari et al. | Evaluation of diagnostic value of Elisa method (EIA) & PCR in diagnosis of hepatitis C virus in hemodialysis patients | |
| Chomean et al. | Quartz crystal microbalance-based biosensor for the detection of α-thalassemia 1 (SEA deletion). | |
| Mukaide et al. | New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2. 0 | |
| JP2006525351A5 (https=) | ||
| US20110104300A1 (en) | Methods for Screening Chemical, Biological, and Physical Agents for Disinfecting Infectious Norovirus | |
| Katsurada et al. | Circulating antibody to hepatitis B core antigen does NOT always reflect the latent hepatitis B virus infection in the liver tissue |